These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7484490)

  • 41. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
    Sørensen EV; Faergeman O; Day MA; Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
    Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
    Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Xamoterol in sinus node disease.
    Avery PG; Small J; Shaw DB
    Int J Cardiol; 1993 Jun; 40(1):45-9. PubMed ID: 8349365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol.
    Erlemeier HH; Kupper W; Bleifeld W
    Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure.
    Hutcheon D; Nemeth E; Quinlan D
    J Clin Pharmacol; 1980 Jan; 20(1):59-68. PubMed ID: 7358869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
    Timewell RM; Stark RD; Marlow HF
    Eur Heart J; 1990 Apr; 11 Suppl A():62-4. PubMed ID: 1971596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring.
    Wang R; Camm J; Ward D; Washington H; Martin A
    J Am Geriatr Soc; 1980 Dec; 28(12):529-34. PubMed ID: 7430528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
    Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction between digoxin and dronedarone in the PALLAS trial.
    Hohnloser SH; Halperin JL; Camm AJ; Gao P; Radzik D; Connolly SJ;
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1019-25. PubMed ID: 25378467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diltiazem as adjunctive oral therapy in patients with chronic atrial fibrillation.
    Gupta MS; Gupta D
    J Assoc Physicians India; 1992 Nov; 40(11):737-9. PubMed ID: 1307536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.
    Hays JV; Gilman JK; Rubal BJ
    Ann Emerg Med; 1994 Jul; 24(1):61-4. PubMed ID: 8010550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
    European 'Corwin' Study Group
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation.
    Kochiadakis GE; Kanoupakis EM; Igoumenidis NE; Mavrakis HE; Kafarakis PK; Vardas PE
    Hellenic J Cardiol; 2005; 46(5):336-40. PubMed ID: 16295942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.